We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada's Drug Listing System Limits Access to New Drugs, Study Says
Canada's Drug Listing System Limits Access to New Drugs, Study Says
January 15, 2007
A new industry-backed study of Canada’s pharmaceutical reimbursement policy and listing recommendations made by four other countries concludes that Canadian patients have “significantly fewer” options when it comes to breakthrough medicines.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor